Re: Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
Dear Authors of this Meta-Analysis:
I think it would be very much insightful having your actual opinions regarding the more clear appearance, nowadays, of serious side-effects of GLP-1 receptor agonists as I mentioned in my first and second responses to this article, even because in your article it was clearly mentioned that there were no signs of increased incidence of acute pancreatitis associated with exenatide, liraglutide, and sitagliptin. Not to mention also human cancers.
Best Regards,
Jose Mario F. de Oliveira, MD, Ph.D.
Competing interests:
No competing interests
25 April 2013
Jose Mario Franco de Oliveira
Associate Professor of Medicine
Universidade Federal Fluminense
Rua Senador Vergueiro # 2 apt. 202. ZIP CODE: 22230-001, Rio de Janeiro, Brazil.
Rapid Response:
Re: Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
Dear Authors of this Meta-Analysis:
I think it would be very much insightful having your actual opinions regarding the more clear appearance, nowadays, of serious side-effects of GLP-1 receptor agonists as I mentioned in my first and second responses to this article, even because in your article it was clearly mentioned that there were no signs of increased incidence of acute pancreatitis associated with exenatide, liraglutide, and sitagliptin. Not to mention also human cancers.
Best Regards,
Jose Mario F. de Oliveira, MD, Ph.D.
Competing interests: No competing interests